新器官共享联合网络分配系统中2类患者等待时间增加:对等待名单及移植后结局的影响
该研究基于美国器官共享联合网络登记系统,纳入2019年1月至2022年6月列为2类的成人患者共6310例,分析等待时间、等待名单事件及移植后结局的时间趋势。结果显示2类患者每日新增数量从4.2例增至5.9例,中位等待时间从18天增至23天,90天内移植概率逐渐下降,且等待时间延长与移植后30天死亡率独立相关。
要点
- 2019年至2022年,每日新增2类患者从4.2例增至5.9例,2类 listing 时使用微轴流心室辅助装置的比例随时间增加(P < .001)。
- 中位等待时间从18天增至23天(P < .001),2类状态天数从8天增至12天(P < .001),等待名单死亡率稳定在5.5%。
- 2类 listing 后90天内移植概率逐渐下降(P < .001),等待时间延长与移植后30天死亡率独立相关(比值比1.01,95%CI 1.00-1.01,P = .02)。
核心结论
- 分配政策改变后,列为2类的患者数量稳步增加,导致等待时间延长和2类患者移植概率降低,可能对移植后结局产生负面影响。
研究设计与样本
- 回顾性队列研究,基于美国器官共享联合网络登记系统,纳入2019年1月至2022年6月列为2类的成人患者共6310例。
主要发现
- 2019年至2022年,每日新增2类患者从4.2例增至5.9例,2类 listing 时使用微轴流心室辅助装置的比例随时间增加(P < .001)。
- 中位等待时间从18天增至23天(P < .001),2类状态天数从8天增至12天(P < .001),等待名单死亡率稳定在5.5%。
- 2类 listing 后90天内移植概率逐渐下降(P < .001)。
- 等待时间延长与移植后30天死亡率独立相关(比值比1.01,95%CI 1.00-1.01,P = .02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Since the heart transplant allocation policy change in 2018, there has been an increase in temporary mechanical circulatory support for Status 2 patients. We sought to examine the temporal pattern of waitlist and posttransplant outcomes for Status 2 patients. METHODS: Adult patients in the United Network for Organ Sharing registry who were listed as Status 2 from January 2019 to June 2022 were included. Temporal trends in waitlist time, waitlist events, and posttransplant outcomes were assessed. Probability of transplant or death after being listed was compared over time. Multivariable regression was performed to identify risk factors for mortality after transplant. RESULTS: A total of 6310 patients were included. From 2019 to 2022, the number of Status 2 patients listed increased from 4.2 to 5.9 per day. Microaxial ventricular assist devices at Status 2 listing increased over time (P < .001). During the study period, median waitlist time (18 days vs 23 days, P < .001) as well as Status 2 days (8 days vs 12 days, P < .001) increased. Waitlist mortality remained stable (5.5%); however, probability of transplant within 90 days of Status 2 listing progressively declined (P < .001). Finally, longer waitlist duration was independently associated with 30-day posttransplant mortality (odds ratio, 1.01; 95% confidence interval, 1.00-1.01, P = .02). CONCLUSIONS: Since the allocation policy change there has been a steady rise in the number of patients listed for Status 2. This has led to increasing waitlist times and lower probability of transplantation for Status 2 patients, which may have negative consequences for posttransplant outcomes.
引用
- Singh SK, Hassanein M, Ning Y, et al. Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes. J Thorac Cardiovasc Surg. 2023. PMID: 37330208. doi:10.1016/j.jtcvs.2023.05.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。